Literature DB >> 25702534

Nocebo and the potential harm of 'high risk' labelling: a scoping review.

Andrew Symon1, Brian Williams2, Qadir A Adelasoye3, Helen Cheyne2.   

Abstract

AIMS: A discussion of the existence, prevalence and characteristics of the nocebo effect in health care.
BACKGROUND: There is increasing but inconsistent evidence for nocebo effects (the opposite of placebo). Causal mechanisms are believed to be similar to placebo (negative effects result from suggestions of negative clinical outcomes). Risk screening in health care may produce this unintended effect through labelling some patients as high risk. Given health care's almost universal coverage this potentially affects many people.
DESIGN: Discussion paper following a scoping review of the existence and frequency of nocebo. DATA SOURCES: Literature databases (PsycINFO, MEDLINE, CCTR, CINAHL and EMBASE) searched from inception dates to 2013. IMPLICATIONS FOR NURSING: Significant empirical evidence indicates that negative beliefs may impact on health outcomes (incidence estimates range from 3-27%). The nocebo effect, rooted in the complex interplay between physiological functioning and social factors, appears significantly more common among women and where prior negative knowledge or expectations exist. Pre-existing psychological characteristics (anxiety, neuroses, panic disorder or pessimism) exacerbate it.
CONCLUSION: While the placebo effect is well documented, there has been no systematic attempt to synthesize primary empirical research on the role of nocebo. It is possible that nocebo outcomes may be preventable through careful consideration of information provision and the prior identification of potentially high risk individuals. This paper summarizes the scale and importance of the nocebo effect, its distribution according to a range of social and clinical variables and its known relation to psychological precursors. It identifies important gaps in the research literature.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  biopsychosocial model of health and illness; conceptual model; negative placebo; nocebo; nursing theory; psychosocial correlates

Mesh:

Year:  2015        PMID: 25702534     DOI: 10.1111/jan.12637

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  5 in total

1.  Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteers.

Authors:  Frank Erbguth; Angelika Hamacher-Erbguth; Uwe Fuhr; Fritz Sörgel
Journal:  Eur J Clin Pharmacol       Date:  2015-08-14       Impact factor: 2.953

Review 2.  Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.

Authors:  S A S A Bemelmans; K Tromp; E M Bunnik; R J Milne; S Badger; C Brayne; M H Schermer; E Richard
Journal:  Alzheimers Res Ther       Date:  2016-11-10       Impact factor: 6.982

3.  Minimizing Drug Adverse Events by Informing About the Nocebo Effect-An Experimental Study.

Authors:  Yiqi Pan; Timm Kinitz; Marin Stapic; Yvonne Nestoriuc
Journal:  Front Psychiatry       Date:  2019-07-25       Impact factor: 4.157

4.  Women's motivations for choosing a high risk birth setting against medical advice in the Netherlands: a qualitative analysis.

Authors:  Martine Hollander; Esteriek de Miranda; Jeroen van Dillen; Irene de Graaf; Frank Vandenbussche; Lianne Holten
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-16       Impact factor: 3.007

Review 5.  The impact of contextual factors on nursing outcomes and the role of placebo/nocebo effects: a discussion paper.

Authors:  Alvisa Palese; Giacomo Rossettini; Luana Colloca; Marco Testa
Journal:  Pain Rep       Date:  2019-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.